InterCure (INCR) Short Interest Ratio & Short Volume → Pentagon contract could send this $2 AI stock soaring (From Behind the Markets) (Ad) Free INCR Stock Alerts $2.67 +0.07 (+2.69%) (As of 04/24/2024 ET) Add Compare Share Share Short InterestStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial Media InterCure Short Interest DataCurrent Short Volume90,200 sharesPrevious Short Volume105,600 sharesChange Vs. Previous Month-14.58%Dollar Volume Sold Short$244,442.00Short Interest Ratio / Days to Cover1.0Last Record DateMarch 31, 2024Outstanding Shares45,570,000 sharesFloat Size27,370,000 sharesShort Percent of Float0.33%Today's Trading Volume27,264 sharesAverage Trading Volume80,600 sharesToday's Volume Vs. Average34% Short Selling InterCure ? Sign up to receive the latest short interest report for InterCure and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatINCR Short Interest Over TimeINCR Days to Cover Over TimeINCR Percentage of Float Shorted Over Time Ad Behind the MarketsPentagon contract could send this $2 AI stock soaringWhenever the Department of Defense awards a major AI contract... Early investors could see dramatic returns virtually overnight. That's how my readers were able to cash in gains like 133% in just four months on C3.ai...Get all the info here >>> InterCure Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/31/202490,200 shares $244,442.00 -14.6%0.3%1 $2.71 3/15/2024105,600 shares $195,360.00 -23.7%0.4%1.3 $1.85 2/29/2024138,400 shares $271,264.00 +3.6%0.5%1.9 $1.96 2/15/2024133,600 shares $233,800.00 -31.7%0.5%1.9 $1.75 1/31/2024195,700 shares $230,926.00 -9.6%0.7%2.6 $1.18 1/15/2024216,400 shares $318,108.00 +7.3%0.8%4.3 $1.47 Get the Latest News and Ratings for INCR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for InterCure and its competitors with MarketBeat's FREE daily newsletter. 12/31/2023201,600 shares $260,023.68 -2.0%0.7%4.4 $1.29 12/15/2023205,600 shares $248,776.00 -4.6%0.8%4.7 $1.21 11/30/2023215,600 shares $263,032.00 +317.8%0.8%5 $1.22 11/15/202351,600 shares $65,532.00 +11.5%0.2%1.1 $1.27 10/31/202346,300 shares $46,763.00 +13.2%0.2%1.1 $1.01 10/15/202340,900 shares $53,579.00 +18.9%0.2%1 $1.31 9/30/202334,400 shares $54,008.00 -42.6%0.1%0.8 $1.57 9/15/202359,900 shares $101,231.00 +71.6%0.2%1.2 $1.69 8/31/202334,900 shares $56,189.00 +156.6%0.1%0.8 $1.61 8/15/202313,600 shares $20,808.00 -28.0%0.1%0.3 $1.53 7/31/202318,900 shares $30,051.00 -62.2%0.1%0.4 $1.59 7/15/202350,000 shares $82,000.00 +36.6%0.2%1.1 $1.64 6/30/202336,600 shares $62,220.00 -11.6%0.1%0.8 $1.70 6/15/202341,400 shares $88,182.00 +18.3%0.2%0.9 $2.13 5/31/202335,000 shares $67,900.00 -40.2%0.1%0.6 $1.94 5/15/202358,500 shares $150,930.00 +28.9%0.2%0.9 $2.58 4/30/202345,400 shares $105,782.00 -15.9%0.2%0.7 $2.33 4/15/202354,000 shares $120,960.00 -16.4%0.2%0.8 $2.24 3/31/202364,600 shares $131,784.00 -26.5%0.2%1 $2.04 3/15/202387,900 shares $169,647.00 +13.3%0.3%1.5 $1.93 2/28/202377,600 shares $191,672.00 +7.3%0.3%1.9 $2.47 2/15/202372,300 shares $245,820.00 -39.9%0.3%1.9 $3.40 1/31/2023120,200 shares $442,336.00 +71.2%0.4%3.9 $3.68 1/15/202370,200 shares $267,462.00 -12.6%0.3%2.7 $3.81 12/30/202280,300 shares $264,990.00 -13.4%0.3%3.5 $3.30 12/15/202292,700 shares $396,756.00 +1.0%0.3%3 $4.28 11/30/202291,800 shares $455,328.00 +71.6%0.3%2.4 $4.96 11/15/202253,500 shares $281,410.00 -40.3%0.2%1.2 $5.26 10/31/202289,600 shares $431,872.00 -5.5%0.3%1.3 $4.82 10/15/202294,800 shares $430,392.00 +5.1%0.4%1.4 $4.54 9/30/202290,200 shares $405,900.00 +58.5%0.3%1.3 $4.50 9/15/202256,900 shares $249,791.00 -31.5%0.2%0.9 $4.39 8/31/202283,000 shares $429,110.00 +14.6%0.3%1.5 $5.17 8/15/202272,400 shares $450,328.00 -9.1%0.3%1.4 $6.22Pentagon contract could send this $2 AI stock soaring (Ad)Whenever the Department of Defense awards a major AI contract... Early investors could see dramatic returns virtually overnight. That's how my readers were able to cash in gains like 133% in just four months on C3.ai...Get all the info here >>> INCR Short Interest - Frequently Asked Questions What is InterCure's current short interest? Short interest is the volume of InterCure shares that have been sold short but have not yet been closed out or covered. As of March 31st, traders have sold 90,200 shares of INCR short. 0.33% of InterCure's shares are currently sold short. Learn More on InterCure's current short interest. What is a good short interest ratio for InterCure? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. INCR shares currently have a short interest ratio of 1.0. Learn More on InterCure's short interest ratio. Which institutional investors are shorting InterCure? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of InterCure: Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for InterCure? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.33% of InterCure's floating shares are currently sold short. Is InterCure's short interest increasing or decreasing? InterCure saw a decline in short interest in the month of March. As of March 31st, there was short interest totaling 90,200 shares, a decline of 14.6% from the previous total of 105,600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is InterCure's float size? InterCure currently has issued a total of 45,570,000 shares. Some of InterCure's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. InterCure currently has a public float of 27,370,000 shares. How does InterCure's short interest compare to its competitors? 0.33% of InterCure's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to InterCure: Cellectar Biosciences, Inc. (8.66%), Annovis Bio, Inc. (13.62%), PDS Biotechnology Co. (16.77%), Adagene Inc. (0.04%), Emergent BioSolutions Inc. (11.38%), Immunic, Inc. (3.37%), IO Biotech, Inc. (0.16%), Cartesian Therapeutics, Inc. (5.31%), Anixa Biosciences, Inc. (1.90%), Societal CDMO, Inc. (0.00%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($4.49 billion), T-Mobile US, Inc. ($3.94 billion), General Motors ($3.34 billion), Charter Communications, Inc. ($3.32 billion), Occidental Petroleum Co. ($3.21 billion), Super Micro Computer, Inc. ($3.13 billion), Coinbase Global, Inc. ($3.08 billion), Moderna, Inc. ($2.28 billion), Tractor Supply ($2.24 billion), and Royal Caribbean Cruises Ltd. ($2.14 billion). View all of the most shorted stocks. What does it mean to sell short InterCure stock? Short selling INCR is an investing strategy that aims to generate trading profit from InterCure as its price is falling. INCR shares are trading up $0.09 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against InterCure? A short squeeze for InterCure occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of INCR, which in turn drives the price of the stock up even further. How often is InterCure's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including INCR, twice per month. The most recent reporting period available is March, 31 2024. More Short Interest Resources from MarketBeat Related Companies: CLRB Short Interest ANVS Short Interest PDSB Short Interest ADAG Short Interest EBS Short Interest IMUX Short Interest IOBT Short Interest RNAC Short Interest ANIX Short Interest SCTL Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:INCR) was last updated on 4/24/2024 by MarketBeat.com Staff From Our PartnersHe Is Giving Away BitcoinCrypto Swap Profitstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressPentagon contract could send this $2 AI stock soaringBehind the MarketsDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersThe #1 Crypto for 2024InvestorPlace